new glp 1 drug retatrutide “Let’s talk — the newest multi-agonist making waves in metabolic medicine. This next-gen medication targets not one, not two, but three key receptors: GLP-1, GIP, and glucagon. The result? Retatrutide Promises Big Weight Loss,

Percentages of proliferative (BrdU + ) (n = 6 technical replicates representative of 2 independent experiments) ( a ) and apoptotic (Annexin V + ) (n = 3 technical replicates representative of 3 independent experiments, **p = 0.0042) ( b ) cells were determined

doi: 10.1007/978-1-4939-7104-6_2 269 Masso-SilvaJ.EspinosaV.LiuT

They have been developed to make it super easy for customers to reach the recommended 30g a day of fibre, says M&S head of food nutrition Grace Ricotti

Continued use and rapid adoption of the most popular GLP-1s, and a rich pipeline suggest this estimate is achievable

It might take a few minutes, but it will fully dissolve into a clear liquid